Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: SH PHARMA(02607) the Revenue is 83.34 B (+7.5%), Beat estimate;the EBIT is 3.722 B (-27.44%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
83.34B7.50%
79.05B1.97%
+4.29B5.53%
EBITExceed expectations
3.72B27.44%
2.56B50.14%
+1.16B22.70%
EPS
TBA--
0.663--
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf